𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Gene therapy in flap survival

✍ Scribed by William Waller; Jonathan Lee; Feng Zhang; William C. Lineaweaver


Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
85 KB
Volume
24
Category
Article
ISSN
0738-1085

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Growth factors are members of a large functional group of polypeptide regulatory molecules that exert a powerful influence on all phases of wound healing and repair through interactions with specific cell surface receptors. The use of growth factors to improve wound healing and the viability of ischemic skin flaps has been well‐documented throughout the last decade. In this article, we review the literature concerning the use gene therapy in flap survival, including the various methods employed to transplant plasmids or viruses capable of coding and producing growth factors in ischemic tissue Β© 2004 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Adenovirus-mediated angiopoietin-1 gene
✍ Howard Jung; Raffi Gurunluoglu; Joe Scharpf; Maria Siemionow πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 411 KB

## Abstract This experimental study investigates the feasibility of pretreating the abdominal skin of a rat with subdermal injections of adenovirus encoding angiopoietin‐1 in order to improve postoperative survival of the skin flap. An epigastric skin flap was used as the model in this study. Rats

AdVEGF165 gene transfer increases surviv
✍ R. E. Giunta; T. Holzbach; C. Taskov; P. S. Holm; M. A. Konerding; D. Schams; E. πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 311 KB

## Abstract ## Background Vascular endothelial growth factor (VEGF) is a key regulator of angiogenesis. VEGF A also plays an important role in wound healing of the skin by promoting angiogenesis and by stimulating blood vessel growth. Therefore we tested the hypothesis that flap survival could be

Gene therapy with adenovirus-mediated VE
✍ Raffi Gurunluoglu; Romed Meirer; Mazier Shafighi; George M. Huemer; Berkhan Yilm πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 405 KB

We investigated the feasibility in rats of enhancing skin-flap prefabrication with subdermal injections of adenovirus-encoding vascular endothelial growth factor (Ad-VEGF). The left saphenous vascular pedicle was used as a source for vascular induction. A peninsular abdominal flap (8 β€’ 8 cm) was ele

Gene delivery methods in cardiac gene th
✍ Kiyotake Ishikawa; Lisa Tilemann; Kenneth Fish; Roger J. Hajjar πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 271 KB

## Abstract Gene therapy for the treatment of heart failure is emerging as a multidisciplinary field demonstrating advances with respect to identifying key signaling pathways, modernized vector creation and delivery technologies. Although these discoveries offer significant progress, selecting opti

Aprotinin in Ischemia-Reperfusion injury
✍ Wayne K. Stadelmann; Derek B. Hess; Martin C. Robson; Daniel P. Greenwald πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 315 KB

Multiple drugs have been used in experimental skin flap models to reduce the effects of reperfusion ischemia. The effects of antiproteases, however, have not been studied. A skin flap ischemia reperfusion model was developed in the rat to study the effects that aprotinin, a broad-spectrum antiserine